Link Technologies has announced the commercialisation and launch of TC RNA Monomers under exclusive license with Agilent Technologies Inc. Under the terms of the agreement Link will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.
Applied Nanotech Holdings, Inc. today announced that Thomas F. Bijou has resigned as Chief Executive Officer, Chairman of the Board, and a member of the Board of Directors of the Company for personal reasons, effective immediately.
Semiconductor Manufacturing International Corporation, one of the leading semiconductor foundries in the world and the most advanced in Mainland China, announced today the availability of a set of 65-nanometer low leakage process IPs, including the preliminary version release of six memory compliers.
Sion Power Corporation and BASF today announced a Joint Development Agreement to accelerate the commercialization of Sion Power's proprietary lithium-sulfur battery technology, e.g., for the electric vehicle market and other high-energy applications.
The development team of Carbonlight Ltd promises that with the help of their new Nanointroscope not only the atom could be observed, but even the electron shells around an atom nucleus will be visible.
The Solution Processable Single Layer Graphene Oxide available from CheapTubes.com and the Graphene Nano Platelets (GNPs) are indeed very different products. Some products are inherently better suited for specific applications even though at first glance competing products may look very similar.
Oxford Instrument has announced the launch of CrystalFlex. This multi-wafer Hydride Vapour Phase Epitaxy (HVPE) reactor provides superb epitaxial growth control, and offers a cost effective route for the production of high quality, crack free epitaxial GaN, AlGaN and AlN single crystal materials.
Nanogen, Inc., developer of molecular and rapid diagnostic products, today announced that it has executed an asset purchase agreement with The Elitech Group, a privately held diagnostics company, to acquire substantially all of the assets of Nanogen. As part of the sale, Nanogen filed a voluntary petition under chapter 11.
Applied DNA Sciences, Inc., a provider of DNA-based security solutions, announced today that it has filed a patent for the embedment of DNA in cyanoacrylate, adding to its extensive intellectual property portfolio, and SigNature DNA product line.